Utility of fibronectin in immuocytochemial differentiation of reactive mesothelial cells from metastatic malignant cells in serous effusions

Indian Journal of Pathology and Microbiology

Volumn 52, Issue 1, 2009, Pages 25-28

  Agarwal, Chetna ^a,b   Jain, Manjula ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

^b A 86   (India)

Author keywords

Carcinoembryonic antigen; Fibronectin; Immunocytochemistry; Serous effusions

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CELL MARKER; FIBRONECTIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CANCER CELL; CARCINOMA CELL; CONTROLLED STUDY; DIFFERENTIATION; EFFUSION; HUMAN; IMMUNOHISTOCHEMISTRY; MESOTHELIUM CELL; METASTASIS;

ADENOCARCINOMA; CARCINOEMBRYONIC ANTIGEN; CELLS; EXUDATES AND TRANSUDATES; FIBRONECTINS; HUMANS; PATHOLOGY, CLINICAL; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING;

EID: 58949097914     PISSN: 03774929     EISSN: None     Source Type: Journal    
DOI: 10.4103/0377-4929.44957     Document Type: Article

References (16)

1. Cajulis RS, Yu GH, Gokaslan T, Hidvegi DF. Modified interphase cytogenetics Technique as an adjunct in the analysis of atypical cells in body fluids. Diagn Cytopathol 1997;16:331-5.
2. Nance KV, Silverman JF. Immunocytochemical panel for the identification of malignant cells in serous effusions. Am J Clin Pathol 1991;95:867-74.
3. Athanassiadou P, Athanassiades P, Lazaris D, Kyrkou K, Petrakakou E Aravantinos D. Immunocytochemical differentiation of reactive mesothelial cells and adenocarcinoma cells in serous effusions with the use of carcinoembryonic antigen and Fibronectin. Acta Cytol 1993;38:718-22.
4. Lee JS, Nam JH, Lee MC, Park CS, Juhng SW. Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serous effusions. Acta Cytol 1996;40:631-6.
5. Koss LG. Effusions in the presence of cancer. In: Koss LG, editor. Diagnostic Cytology and its histopathological basis. 4th ed. Philadelphia: J.B Lippincott Company 1992; p. 1176-84.
6. Moran CA, Suster S. Tumours of lung and pleura. In: Fletcher CD, editor. Diagnostic histopathology of tumors. 2nd ed. Churchill Livigstone; 2001. p. 171-208.
7. Cotran RS, Kumar V, Collins T. Tissue repair: Cellular Growth, fibrosis and wound healing. In: Cotran RS, Kumar V, Collins T, editors. Robbins pathological basis of disease. 6TH ed. WB Saunders Company; 1999. p. 89-112.
8. Haynes RD. Fibronectins. Sci Am 1986;254:42-51.
9. Jaffe EA, Mosher DF. Synthesis of Fibronectin by cultured human endothelial cells. J Exp Med 1978;147:1779-91.
10. Mosher DF. Fibronectin. Frog Hemost Thromb 1980;5:111-5.
11. Doglioni C, Tos AP, Laurino L, Iuzzolino P, Chiarelli C, Celio MR, et al. Calretinin: Novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996;20:1037-46.
12. Riera JR, Astengo-Osuna C, Longmate JA, Battifora H. The immunohistochemical diagnostic panel for epithelial mesothelioma: A reevaluation after heat induced epitope retrieval. Am J Surg Pathol 1997;21:1409-19.
13. Ordonez NG. Value of antibodies 44-3AG, SM3, HBME-l and thrombomodulin in differentiating epithelial pleural mesotheliomas from lung adenocarcinoma: A comparative study with other commonly used antibodies. Am J Surg Pathol 1997;21:1399-408.
14. Barr NJ, Wu NC, Taylor CR. Immunohistochemistry and diagnostic pathology. In: Bancroft JD, Gamble M, editors. Theory and Practice of Histological techniques. 5th ed. Churchill Livingstone; 2003. p. 537-52.
15. Gold P, Freedman SO. Demonstration of tumor specific antigen in human colonic carcinomata by immunological tolerance and absorbtion techniques. J Exp Med 1965;121:4398-62.
16. Mezger J, Stotzer O, Schilli G, Bauer S, Wilmanns W. Identification of carcinoma cells in ascetic and pleural fluid: Comparison of four panepithelial antigens with carcinoembryonic antigen. Acta Cytol 1992;36:75-81.